This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 7 EPO patents. Top assignees: Amplidiag Oy, Gen-Probe, Inc., Mobidiag Ltd.. Active years: 2017-2026.
Location History:
- Helsinki, FI (2017)
- Espoo, FI (2018 - 2023)
Company Filing History:
2 out of 2 
1 out of 840 
1 out of 1 Years Active: 2017-2026
Title: Juha Kirveskari: Innovator in Pathogen Detection
Introduction
Juha Kirveskari is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pathogen detection, holding a total of four patents. His work focuses on developing methods that enhance the detection of harmful microorganisms in various samples.
Latest Patents
Kirveskari's latest patents include a method for detecting the presence of a hypervirulent strain. This invention provides a nucleic acid amplification-based method for identifying hypervirulent strains in biological samples. It utilizes oligonucleotide primers and probes that are specific to both negative and positive markers in the hypervirulent genome. Another significant patent is a method for determining the presence of diarrhoea-causing pathogens. This invention relates to the detection of such pathogens from patient, food, or environmental samples. It offers a polymerase chain reaction (PCR) based assay method, particularly a multiplex real-time PCR (RT-PCR) assay, for the rapid determination of clinically important pathogens related to traveller's diarrhoea.
Career Highlights
Throughout his career, Kirveskari has worked with various companies, including Amplidiag Oy and Mobidiag Ltd. His experience in these organizations has contributed to his expertise in the field of pathogen detection and diagnostics.
Collaborations
Some of his notable coworkers include Jaakko Kurkela and Jenni Antikainen. Their collaboration has likely played a role in advancing the research and development of innovative detection methods.
Conclusion
Juha Kirveskari's contributions to pathogen detection through his patents and collaborations highlight his importance in the field of medical diagnostics. His innovative methods continue to pave the way for advancements in identifying harmful pathogens effectively.